AL
Congress trade
Rep. Alan Lowenthal (D-CA) bought $903-$903 of BioMarin Pharmaceutical Inc. (BMRN) stock
Alan Lowenthal, U.S. Representative (D-CA), disclosed a purchase of BioMarin Pharmaceutical Inc. (BMRN) stock worth $903-$903 in a STOCK Act filing on Jun 10, 2018.
The trade happened on May 29, 2018, 12 days before it was made public.
BMRN has moved -35.5% since the trade date, from $90.54 to $58.44 (Oct 1, 2026 close).
- Traded
- May 29, 2018
- Disclosed
- Jun 10, 2018
- Filing delay
- 12 days
- Price since
- -35.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (4)
More BMRN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.